Wednesday, June 19, 2013 Last update: 7:38 PM
Company Tech News as it Breaks
Trade Events
EXACT Sciences Corp.
News articles for EXACT Sciences Corp.:
Tuesday, June 18, 2013
- Exact Sciences Prices Public Offering of Common StockExact Sciences Corp. (NASDAQ: EXAS) today announced the pricing of its previously announced underwritten public offering of 5.5 million shares of its common stock, offered at a price ... read more
Monday, June 17, 2013
- Exact Sciences Announces Proposed Public Offering of Common StockExact Sciences Corp. (NASDAQ: EXAS) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject ... read more
Monday, June 10, 2013
- Exact Sciences Submits Final Module and Completes Cologuard Premarket Approval Application to FDA, Expands Role of COO AroraExact Sciences Corp. (Nasdaq: EXAS) today announced that it has submitted to the U.S. Food and Drug Administration the final module of the premarket approval (PMA) application for ... read more
Monday, June 3, 2013
- Exact Sciences to Participate in June Investor ConferencesExact Sciences Corp. (Nasdaq: EXAS) today announced that the company will participate in three investor conferences during June. Maneesh K. Arora, ... read more
Wednesday, May 1, 2013
- Exact Sciences Reports First-Quarter 2013 Financial Results, Announces Addition to Board of DirectorsExact Sciences Corp. (Nasdaq: EXAS) today announced its financial results for the quarter ended March 31, 2013. Exact reported total revenues ... read more
Friday, April 26, 2013
- Exact Sciences to Host First-Quarter 2013 Results Webcast and CallExact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host a webcast and conference call to discuss its first-quarter 2013 financial results on May 1, 2013. ... read more
Thursday, April 18, 2013
- Top-Line Data Show Exact Sciences’ Cologuard Test Demonstrates 92 Percent Sensitivity in the Detection of Colorectal CancerExact Sciences Corp. (Nasdaq: EXAS) today announced that preliminary analysis shows that the company’s Cologuard colorectal cancer screening test met or exceeded all primary and secondary endpoints of ... read more
Wednesday, April 17, 2013
- Exact Sciences Schedules Announcement and Call for Top-Line Results of DeeP-C Clinical TrialExact Sciences Corp. (Nasdaq: EXAS) will announce the preliminary, top-line results of its DeeP-C pivotal clinical trial on Thursday, April 18, 2013, prior to the market open. The ... read more
Monday, March 11, 2013
- Exact Sciences to Participate in 25th Annual Roth ConferenceExact Sciences Corp. (Nasdaq: EXAS) today announced that it will present at the 25th Annual Roth Conference in Dana Point, Calif. ... read more
Wednesday, February 20, 2013
- Exact Sciences Reports Fourth-Quarter 2012 Financial ResultsExact Sciences Corp. (Nasdaq: EXAS) today announced its financial results for the quarter and year ended Dec. 31, 2012. Exact reported ... read more
Tuesday, February 12, 2013
- Exact Sciences to Participate in February Investor ConferencesExact Sciences Corp. (Nasdaq: EXAS) today announced that it will present at two investor conferences during February. Kevin T. Conroy, Exact’s ... read more
Thursday, January 3, 2013
- Exact Sciences to Participate in J.P. Morgan Healthcare ConferenceExact Sciences Corp. (Nasdaq: EXAS) today announced that it will present at the J.P. Morgan Healthcare Conference in San Francisco. Kevin ... read more